BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 26517296)

  • 1. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.
    Kelemen K; Holden J; Johnson LJ; Davion S; Robetorye RS
    Cytometry B Clin Cytom; 2017 Jul; 92(4):310-314. PubMed ID: 26517296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis.
    Liu W; Hu S; Konopleva M; Khoury JD; Kalhor N; Tang G; Bueso-Ramos CE; Jorgensen JL; Lin P; Medeiros LJ; Lu X
    Pediatr Hematol Oncol; 2015; 32(8):535-47. PubMed ID: 26558423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomorphologic findings of B-cell lymphomas with concurrent IGH/BCL2 and MYC rearrangements (dual-translocation lymphomas).
    da Cunha Santos G; Ko HM; Saieg MA; Boerner SL; Lai SW; Bailey D; Geddie WR
    Cancer Cytopathol; 2011 Aug; 119(4):254-62. PubMed ID: 21560251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
    Li S; Lin P; Fayad LE; Lennon PA; Miranda RN; Yin CC; Lin E; Medeiros LJ
    Mod Pathol; 2012 Jan; 25(1):145-56. PubMed ID: 22002575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.
    Kanda-Akano Y; Nomura K; Fujita Y; Horiike S; Nishida K; Nagai M; Miura I; Nakamura S; Seto M; Iida S; Ueda R; Taniwaki M
    Leuk Lymphoma; 2004 Aug; 45(8):1559-67. PubMed ID: 15370207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement.
    Yoon J; Yun JW; Jung CW; Ju HY; Koo HH; Kim SH; Kim HJ
    Genes Chromosomes Cancer; 2020 Apr; 59(4):255-260. PubMed ID: 31705772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B Lymphoblastic Leukemia/Lymphoma With Burkitt-like Morphology and IGH/MYC Rearrangement: Report of 3 Cases in Adult Patients.
    Li Y; Gupta G; Molofsky A; Xie Y; Shihabi N; McCormick J; Jaffe ES
    Am J Surg Pathol; 2018 Feb; 42(2):269-276. PubMed ID: 29112016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow Cytometric Evaluation of Double/Triple Hit Lymphoma.
    Roth CG; Gillespie-Twardy A; Marks S; Agha M; Raptis A; Hou JZ; Farah R; Lin Y; Qian Y; Pantanowitz L; Boyiadzis M
    Oncol Res; 2016; 23(3):137-46. PubMed ID: 26931436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
    Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A leukemic double-hit follicular lymphoma associated with a complex variant translocation, t(8;14;18)(q24;q32;q21), involving BCL2, MYC, and IGH.
    Minakata D; Sato K; Ikeda T; Toda Y; Ito S; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Oh I; Fujiwara SI; Ohmine K; Kawata H; Muroi K; Miura I; Kanda Y
    Cancer Genet; 2018 Jan; 220():44-48. PubMed ID: 29310838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia.
    Kalff A; Khong T; Wall M; Gorniak M; Mithraprabhu S; Campbell LJ; Spencer A
    Haematologica; 2015 Feb; 100(2):e60-2. PubMed ID: 25381133
    [No Abstract]   [Full Text] [Related]  

  • 12. Establishment and characterization of a novel MYC/BCL2 "double-hit" diffuse large B cell lymphoma cell line, RC.
    Pham LV; Lu G; Tamayo AT; Chen J; Challagundla P; Jorgensen JL; Medeiros LJ; Ford RJ
    J Hematol Oncol; 2015 Oct; 8():121. PubMed ID: 26515759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytopathology of "double-hit" non-Hodgkin lymphoma.
    Elkins CT; Wakely PE
    Cancer Cytopathol; 2011 Aug; 119(4):263-71. PubMed ID: 21560252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aggressive B-cell lymphoma with IGH/MYC, IGH/BCL2, and IGH/CCND1 translocations].
    Nishijima A; Noguchi Y; Narukawa K; Takano H; Oshikawa G
    Rinsho Ketsueki; 2019; 60(10):1425-1430. PubMed ID: 31695002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Cutaneous Diffuse Large B-Cell Lymphoma With a MYC-IGH Rearrangement and Gain of BCL2: Expanding the Spectrum of MYC/BCL2 Double-Hit Lymphomas.
    Testo N; Olson LC; Subramaniyam S; Hanson T; Magro CM
    Am J Dermatopathol; 2016 Oct; 38(10):769-74. PubMed ID: 27391453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Approach for Double-Hit and Triple-Hit Lymphoma Based on Immunophenotypic and Cytogenetic Characteristics of Bone Marrow Specimens.
    Kim H; Kim HJ; Kim SH
    Ann Lab Med; 2020 Sep; 40(5):361-369. PubMed ID: 32311849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular lymphoma transformed to "double-hit" B lymphoblastic lymphoma presenting in the peritoneal fluid.
    Kaplan A; Samad A; Dolan MM; Cioc AM; Holman CJ; Schmechel SC; Pambuccian SE
    Diagn Cytopathol; 2013 Nov; 41(11):986-90. PubMed ID: 22623514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.
    Adams T; Fuchs D; Shadoan PK; Johnstone L; Lau BM; McGhan L; Anwer F; Al-Kateb H
    Cancer Genet; 2018 Apr; 222-223():25-31. PubMed ID: 29666005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphomas with pseudo-double-hit BCL6-MYC translocations due to t(3;8)(q27;q24) are associated with a germinal center immunophenotype, extranodal involvement, and frequent BCL2 translocations.
    Johnson SM; Umakanthan JM; Yuan J; Fedoriw Y; Bociek RG; Kaiser-Rogers K; Sanmann JN; Montgomery ND
    Hum Pathol; 2018 Oct; 80():192-200. PubMed ID: 29902576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.